Use of Clostridium perfringens enterotoxin and the enterotoxin receptor-binding domain (C-CPE) for cancer treatment: Opportunities and challenges

Journal of Toxicology

Volumn 2012, Issue , 2012, Pages

  Gao, Zhijian ^a   McClane, Bruce A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CLAUDIN 3; CLAUDIN 4; CLOSTRIDIUM PERFRINGENS ENTEROTOXIN; CLOSTRIDIUM PERFRINGENS ENTEROTOXIN RECEPTOR; ENTEROTOXIN; PSEUDOMONAS AERUGINOSA EXOTOXIN A; RECEPTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; CLOSTRIDIUM PERFRINGENS; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; TUMOR XENOGRAFT;

CLOSTRIDIUM PERFRINGENS;

EID: 81555221756     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2012/981626     Document Type: Review

References (41)

1. McClane B. A., Uzal F. A., Miyakawa M. F., Lyerly D., Wilkins T. D., Falkow S., Dworkin M., Rosenburg E., Schleifer H., Stackebrandt E., The enterotoxic clostridia The Prokaryotes 2006 New York, NY, USA Springer 688 752
2. McClane B. A., Doyle M. P., Beuchat L. R., Clostridium perfringens Food Microbiology: Fundamentals and Frontiers 2007 3rd Washington, DC, USA ASM Press 423 444
3. Sarker M. R., Carman R. J., McClane B. A., Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe -positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops Molecular Microbiology 1999 33 5 946 958 (Pubitemid 29425247)
4. Collie R. E., McClane B. A., Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with non-food-borne human gastrointestinal diseases Journal of Clinical Microbiology 1998 36 1 30 36 (Pubitemid 28047428)
5. Miyamoto K., Fisher D. J., Li J., Sayeed S., Akimoto S., McClane B. A., Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates Journal of Bacteriology 2006 188 4 1585 1598 (Pubitemid 43228692)
6. Brynestad S., Sarker M. R., McClane B. A., Granum P. E., Rood J. I., The enterotoxin (CPE) plasmid from Clostridium perfringens is conjugative Infection and Immunity 2001 69 5 3483 3487 (Pubitemid 32332254)
7. Parsons J. A., Bannam T. L., Devenish R. J., Rood J. I., TcpA, an FtsK/SpoIIIE homolog, is essential for transfer of the conjugative plasmid pCW3 in Clostridium perfringens Journal of Bacteriology 2007 189 21 7782 7790 (Pubitemid 350035088)
8. Harry K. H., Zhou R., Kroos L., Melville S. B., Sporulation and enterotoxin (CPE) synthesis are controlled by the sporulation-specific sigma factors SigE and SigK in Clostridium perfringens Journal of Bacteriology 2009 191 8 2728 2742
9. Li J., McClane B. A., Evaluating the involvement of alternative sigma factors SigF and SigG in Clostridium perfringens sporulation and enterotoxin synthesis Infection and Immunity 2010 78 10 4286 4293
10. Bos J., Smithee L., McClane B. A., Distefano R. F., Uzal F., Songer J. G., Mallonee S., Crutcher J. M., Fatal necrotizing colitis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection Clinical Infectious Diseases 2005 40 10 e78 e83
11. Robertson S. L., Smedley J. G. III, Singh U., Chakrabarti G., Van Itallie C. M., Anderson J. M., McClane B. A., Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants Cellular Microbiology 2007 9 11 2734 2755 (Pubitemid 47500522)
12. Smedley J. G. III, Uzal F. A., McClane B. A., Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin Infection and Immunity 2007 75 5 2381 2390 (Pubitemid 46744328)
13. Chakrabarti G., McClane B. A., The importance of calcium influx, calpain and calmodulin for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin Cellular Microbiology 2005 7 1 129 146
14. Chakrabarti G., Zhou X., McClane B. A., Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin Infection and Immunity 2003 71 8 4260 4270 (Pubitemid 36919888)
15. Singh U., Van Itallie C. M., Mitic L. L., Anderson J. M., McClane B. A., CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin The Journal of Biological Chemistry 2000 275 24 18407 18417 (Pubitemid 30414798)
16. Rahner C., Mitic L. L., McClane B. A., Anderson J. M., Clostridium perfringens enterotoxin impairs bile flow in the isolated perfused rat liver and induces fragmentation of tight junction fibrils Hepatology 1999 30 326a
17. Van Itallie C. M., Betts L., Smedley J. G. III, McClane B. A., Anderson J. M., Structure of the claudin-binding domain of Clostridium perfringens enterotoxin The Journal of Biological Chemistry 2008 283 1 268 274
18. Kitadokoro K., Nishimura K., Kamitani S., Crystal structure of Clostridium perfringens enterotoxin displays features of beta pore forming toxin The Journal of Biological Chemistry 2011 286 22 19549 19555
19. Smedley J. G. III, McClane B. A., Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis Infection and Immunity 2004 72 12 6914 6923 (Pubitemid 39552358)
20. Kominsky S. L., Tyler B., Sosnowski J., Brady K., Doucet M., Nell D., Smedley J. G., McClane B., Brem H., Sukumar S., Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis Cancer Research 2007 67 17 7977 7982 (Pubitemid 47395128)
21. Harada M., Kondoh M., Ebihara C., Takahashi A., Komiya E., Fujii M., Mizuguchi H., Tsunoda S. I., Horiguchi Y., Yagi K., Watanabe Y., Role of tyrosine residues in modulation of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin Biochemical Pharmacology 2007 73 2 206 214 (Pubitemid 44855729)
22. Anderson J. M., Van Itallie C. M., Physiology and function of the tight junction Cold Spring Harbor Perspectives in Biology 2009 1, article a002584
23. Katahira J., Inoue N., Horiguchi Y., Matsuda M., Sugimoto N., Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin Journal of Cell Biology 1997 136 6 1239 1247 (Pubitemid 27421912)
24. Fujita K., Katahira J., Horiguchi Y., Sonoda N., Furuse M., Tsukita S., Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein FEBS Letters 2000 476 3 258 261 (Pubitemid 30410828)
25. Robertson S. L., Smedley J. G. III, McClane B. A., Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin Infection and Immunity 2010 78 1 505 517
26. Veshnyakova A., Protze J., Rossa J., Blasig I. E., Krause G., Piontek J., On the interaction of Clostridium perfringens enterotoxin with claudins Toxins 2010 2 1336 1356
27. Morin P. J., Claudin proteins in human cancer: promising new targets for diagnosis and therapy Cancer Research 2005 65 21 9603 9606 (Pubitemid 41541431)
28. Litkouhi B., Kwong J., Lo C. M., Smedley J. G., McClane B. A., Aponte M., Gao Z., Sarno J. L., Hinners J., Welch W. R., Berkowitz R. S., Mok S. C., Garner E. I. O., Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin Neoplasia 2007 9 4 304 314 (Pubitemid 46608297)
29. Santin A. D., Cané S., Bellone S., Palmieri M., Siegel E. R., Thomas M., Roman J. J., Burnett A., Cannon M. J., Pecorelli S., Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin Cancer Research 2005 65 10 4334 4342 (Pubitemid 40775672)
30. Kominsky S. L., Vali M., Korz D., Gabig T. G., Weitzman S. A., Argani P., Sukumar S., Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4 The American Journal of Pathology 2004 164 5 1627 1633 (Pubitemid 38529765)
31. Santin A. D., Bellone S., Marizzoni M., Palmieri M., Siegel E. R., McKenney J. K., Hennings L., Comper F., Bandiera E., Pecorelli S., Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE) Cancer 2007 109 7 1312 1322 (Pubitemid 46466558)
32. Michl P., Buchholz M., Rolke M., Kunsch S., Lhr M., McClane B., Tsukita S., Leder G., Adler G., Gress T. M., Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin Gastroenterology 2001 121 3 678 684 (Pubitemid 32822583)
33. Long H., Crean C. D., Lee W. H., Cummings O. W., Gabig T. G., Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium Cancer Research 2001 61 21 7878 7881 (Pubitemid 33049378)
34. Wallace F. M., Mach A. S., Keller A. M., Lindsay J. A., Evidence for Clostridium perfringens enterotoxin (CPE) inducing a mitogenic and cytokine response in vitro and a cytokine response in vivo Current Microbiology 1999 38 2 96 100 (Pubitemid 29046832)
35. Gao Z., Xu X., McClane B., Zeng Q., Litkouhi B., Welch W. R., Berkowitz R. S., Mok S. C., Garner E. I.O., C terminus of Clostridium perfringens enterotoxin downregulates CLDN4 and sensitizes ovarian cancer cells to Taxol and Carboplatin Clinical Cancer Research 2011 17 5 1065 1074
36. Sonoda N., Furuse M., Sasaki H., Yonemura S., Katahira J., Horiguchi Y., Tsukita S., Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier Journal of Cell Biology 1999 147 1 195 204 (Pubitemid 30211807)
37. Yuan X., Lin X., Manorek G., Kanatani I., Cheung L. H., Rosenblum M. G., Howell S. B., Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors Molecular Cancer Therapeutics 2009 8 7 1906 1915
38. Saeki R., Kondoh M., Kakutani H., Tsunoda S.-I., Mochizuki Y., Hamakubo T., Tsutsumi Y., Horiguchi Y., Yagi K., A novel tumor-targeted therapy using a claudin-4-targeting molecule Molecular Pharmacology 2009 76 4 918 926
39. Suzuki H., Kakutani H., Kondoh M., Watari A., Yagi K., The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin Pharmazie 2010 65 10 766 769
40. Uchida H., Kondoh M., Hanada T., Takahashi A., Hamakubo T., Yagi K., A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide Biochemical Pharmacology 2010 79 10 1437 1444
41. Smedley J. G. III, Saputo J., Parker J. C., Fernandez-Miyakawa M. E., Robertson S. L., McClane B. A., Uzal F. A., Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity Infection and Immunity 2008 76 8 3793 3800